|
1439 |
간경변증 |
간경변증 |
2021 |
Non-Invasive Estimation of Hepatic Venous Pressure Gradient
|
Young Seo Cho |
|
509 |
|
1438 |
알코올 간질환 |
알코올 간질환 |
2021 |
Microbiome as a Potential Diagnostic Biomarker in Severe Alcoholic Hepatitis
|
Soon Sun Kim |
|
617 |
|
1437 |
알코올 간질환 |
알코올 간질환 |
2021 |
Prognosis and Outcome of Patients with Alcohol-Associated Acute-On-Chronic Liver Failure
|
Eileen L. Yoon |
|
541 |
|
1436 |
알코올 간질환 |
알코올 간질환 |
2021 |
Clinical, Histological, and Molecular Profiling of Different Stages of Alcohol-Related Steatohepatitis
|
Ramon Bataller |
|
491 |
|
1435 |
알코올 간질환 |
알코올 간질환 |
2021 |
Non-Invasive Diagnosis and Biomarkers in Alcohol-Related Liver Disease
|
Young Kul Jung |
|
486 |
|
1434 |
바이러스 간질환 |
B형 간염 |
2021 |
Latest Treatment Drugs for Hepatitis B and C and Treatment of Hepatitis D and E
|
Wonseok Kang |
|
568 |
|
1433 |
바이러스 간질환 |
B형 간염 |
2021 |
Viral Hepatitis: The Path I have Taken as a Clinician and Researcher of Viral Hepatitis
|
Kwang-Hyub Han |
|
613 |
|
1432 |
간종양 |
간세포암 |
2021 |
Management of Immune-Related Adverse Events Caused by Immune Checkpoint Inhibitors
|
Tae Yong Kim |
|
551 |
|
1431 |
간경변증 |
간경변증 |
2021 |
Early TIPS for Improving Outcomes of Acute Variceal Bleeding: Who Are the Appropriate Candidates?
|
Guohong Han |
|
507 |
|
1430 |
간종양 |
간세포암 |
2021 |
Clinical Application of Liquid Biopsy as a Prognostic Biomarker in Hepatocellular Carcinoma
|
Soo Young Park |
|
534 |
|
1429 |
비알코올 지방간질환 |
비알코올 지방간질환 |
2021 |
Novel Insights of Translational Research in Nonalcoholic Steatohepatitis and Fibrosis
|
Scott Friedman |
|
533 |
|
1428 |
비알코올 지방간질환 |
비알코올 지방간질환 |
2021 |
KASL Clinical Practice Guidelines
|
Yong Kyun Cho |
|
600 |
|
1427 |
비알코올 지방간질환 |
비알코올 지방간질환 |
2021 |
MAFLD vs. NAFLD: What's in the Name? Cons: Premature Proposition
|
Ajay Duseja |
|
558 |
|
1426 |
비알코올 지방간질환 |
비알코올 지방간질환 |
2021 |
Which Is the More Appropriate Surrogate and Target? Liver Fibrosis and/or Inflammation
|
Vincent Wong |
|
546 |
|
1425 |
비알코올 지방간질환 |
비알코올 지방간질환 |
2021 |
Which Is the More Appropriate Surrogate and Target? Metabolic Factors and/or Steatosis
|
Dae Won Jun |
|
530 |
|
1424 |
간종양 |
간세포암 |
2021 |
The Path I have Taken as a Clinician and Researcher with Hepatocellular Carcinoma
|
Joong-Won Park |
|
501 |
|
1423 |
간종양 |
간세포암 |
2021 |
Hepatocellular Carcinoma Tumor Microenvironment
|
Yutaka Kurebayashi |
|
547 |
|
1422 |
간종양 |
간세포암 |
2021 |
Genetic and Molecular/Immune Profiling Analyses for Hepatocellular Carcinoma
|
Naoshi Nishida |
|
529 |
|
1421 |
간종양 |
간세포암 |
2021 |
Hepatocellular Carcinoma Molecular Pathological Classification and Its Practical Applications
|
Haeryoung Kim |
|
538 |
|
1420 |
간종양 |
간세포암 |
2021 |
Hepatocellular Carcinoma Progenitor Phenotype: K19 and Hepatocellular Carcinoma
|
Hyungjin Rhee |
|
520 |